
Source briefing
Human medicines European public assessment report (EPAR): Povofortay, povorcitinib, Status: Opinion
Human medicines European public assessment report (EPAR): Povofortay, povorcitinib, Status: Opinion
Read →
Source briefing
Human medicines European public assessment report (EPAR): Zeydovio, glepaglutide, Status: Opinion
Human medicines European public assessment report (EPAR): Zeydovio, glepaglutide, Status: Opinion
Read →
Source briefing
Human medicines European public assessment report (EPAR): Sepalna, senaparib, Status: Opinion
Human medicines European public assessment report (EPAR): Sepalna, senaparib, Status: Opinion
Read →
Source briefing
Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 10, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 29, Status: Authorised
Read →
Source briefing
Programme of the 2026 annual meeting of the European network of paediatric research at EMA (EnprEMA)
Programme of the 2026 annual meeting of the European network of paediatric research at EMA (EnprEMA)
Read →
Source briefing
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 September 2026
12 new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended 12 medicines for approval at its September 2026 meeting.The committee recommended…, CHMP statistics Key figures from the September 2026 CHMP meeting are represented in the graphic below. © European…
Read →
Source briefing
Communicable disease threats report, 12-18 September, week 38
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 September, and includes updates on Ebola, malaria, botulism, avian influenza A(H9N2), influenza A(H5), respiratory virus epidemiology in the EU/.EEA, West Nile virus infections, chikungunya,…
Read →
Source briefing
Record 32% of new vehicle sales to be EVs in 2030, study finds
Report sees strong growth despite recent loss of federal incentives
Read →
Source briefing
Persistent Bartonella quintana Infection in Macaques at Primate Research Institute, Japan
Y. Nomura et al.
Read →